Facetten
Zugriff
Einrichtung
Medientyp
- Text 18
Karte
Erscheinungsjahr
Autor/in
- Graefen, Markus
- Schlomm, Thorsten 6
- Simon, Ronald 6
- Grupp, Katharina 5
- Huland, Hartwig 5
- alle zeigen
Sprache
- Englisch 18
18 Einträge gefunden
-
High mitochondria content is associated with prostate cancer disease progression
- Grupp, Katharina
- Jedrzejewska, Karolina
- Tsourlakis, Maria Christina
- Koop, Christina
- Wilczak, Waldemar
- Adam, Meike
- Quaas, Alexander
-
Marked heterogeneity of ERG expression in large primary prostate cancers.
- Minner, Sarah
- Gärtner, Michael
- Freudenthaler, Fabian
- Bauer, Melanie
- Kluth, Martina
- Salomon, Georg
- Heinzer, Hans
-
High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers
- Grupp, Katharina
- Sanader, Stella
- Sirma, Hüseyin
- Simon, Ronald
- Koop, Christina
- Prien, Kristina
- Hube-Magg, Claudia
-
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?
- Leyh-Bannurah, Sami-Ramzi
- Hansen, Jens
- Isbarn, Hendrik
- Steuber, Thomas
- Tennstedt, Pierre
- Michl, Uwe
- Schlomm, Thorsten
-
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy
- Grupp, Katharina
- Höhne, Thorsten Simon
- Prien, Kristina
- Hube-Magg, Claudia
- Tsourlakis, Maria Christina
- Sirma, Hüseyin
- Pham, Taher
-
-
Sociodemographic disparities in the treatment of small renal masses.
- Becker, Andreas
- Roghmann, Florian
- Trinh, Quoc-Dien
- Hansen, Jens
- Tian, Zhe
- Shariat, Shahrokh F
- Noldus, Joachim
-
-
CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer
- Burkhardt, Lia
- Fuchs, Sarah
- Krohn, Antje
- Masser, Sawinee
- Mader, Malte
- Kluth, Martina
- Bachmann, Frederik
-
Assays for prostate cancer: changing the screening paradigm?
2013 - Forschungsinformationssystem des UKE -
Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence
- Tsourlakis, Maria Christina
- Schoop, Michael
- Plaß, Christoph
- Huland, Hartwig
- Graefen, Markus
- Steuber, Thomas
- Schlomm, Thorsten
-
External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
- Hansen, Jens
- Rink, Michael
- Bianchi, Marco
- Kluth, Luis A
- Tian, Zhe
- Ahyai, Sascha A
- Shariat, Shahrokh F
-
-
Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy.
- Trinh, Quoc-Dien
- Sukumar, Shyam
- Schmitges, Jan
- Bianchi, Marco
- Sun, Maxine
- Shariat, Shahrokh F
- Sammon, Jesse D
-
Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis
- Briganti, Alberto
- Spahn, Martin
- Joniau, Steven
- Gontero, Paolo
- Bianchi, Marco
- Kneitz, Burkhard
- Chun, Felix K H
-
-
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers
- Krohn, Antje
- Seidel, Annemarie
- Burkhardt, Lia
- Bachmann, Frederik
- Mader, Malte
- Grupp, Katharina
- Eichenauer, Till
-
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers
- Krohn, Antje
- Seidel, Annemarie
- Burkhardt, Lia
- Bachmann, Frederic
- Mader, Malte
- Grupp, Katharina
- Eichenauer, Till